|
Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 Clinical research trials and Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1. Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 clinical trial. Subjects typically recieve the finest healthcare available for their Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1 condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1  Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1
Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1
For Condition: Tobacco Use Disorder
Status: Recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) , New York University School of Medicine
Synopsis: CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy
Details:
Eligibility:
Study Type: Interventional, Treatment, Uncontrolled
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Alcohol or Drug Dependence Inclusion Criteria: - Outpatient Drug-Free or Opiate Substitute program. Interested in quitting smoking Exclusion Criteria: - Psychotic. - Smokeless tobacco - Other Cessasation product - Pregnant - Hyper-tension - Heart problems - Skin condition
Total Enrollment: 864
Location and Contact Information:
Overall Study Official:
MalcolmReid, Principal Investigator, New York University School of Medicine
Matrix Institute on Addictions *Not yet recruiting*
Los Angeles, California,
United States
Not yet recruiting Frank Flammino 212-686-7500
Psychiatry and Behavioral Medicine Professionals I *Recruiting*
Detroit, Michigan,
United States
Recruiting Frank Flammino 212-686-7500
Tarzana Treatment Center *Not yet recruiting*
Tarzana, California, 91356
United States
Not yet recruiting Frank Flammino 212-686-7500
Mount Sinai Medical Center *Recruiting*
New York City, New York,
United States
Recruiting Aron Starosta 212-686-7500
Center for Drug Free Living *No longer recruiting*
Orlando, Florida,
United States
No longer recruiting
Behavioral Health Services of Pickens County *Recruiting*
Pickens, South Carolina,
United States
Recruiting Frank Flammino 212-686-7500
Coastal Horizons Center, Inc. *Recruiting*
Wilmington, North Carolina,
United States
Recruiting Frank Flammino 212-686-7500
SPECTRUM *No longer recruiting*
Miami, Florida,
United States
No longer recruiting
St. Luke's Roosevelt Hospital Center *Recruiting*
New York City, New York,
United States
Recruiting Frank Flammino 212-686-7500
Piedmont Behavioral Healthcare *Recruiting*
Concord, North Carolina,
United States
Recruiting Frank Flammino 212-686-7500
Bridge Plaza - Narco Freedom *Recruiting*
Long Island, New York,
United States
Recruiting Frank Flammino 212-686-7500
Chelsea Arbor Addictions Treatment Center *No longer recruiting*
Ann Arbor, Michigan,
United States
No longer recruiting
Additional Information:
Study ID Numbers: NIDA-CTN-0009-1;
Study Start Date: April 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067158
Other Tobacco Use Disorder Studies:
1. Role of Metabolites in Nicotine Dependence (2) - 5
2. Progesterone Treatment in Female Smokers - 12
3. Role of Metabolites in Nicotine Dependence (4) - 13
4. Role of Metabolites in Nicotine Dependence (3) - 6
5. Role of Metabolites in Nicotine Dependence (1) - 1
Related Studies:
Other Tobacco Use Disorder Clinical Trials
Other Michigan Clinical Trials
Other Detroit Clinical Trials
Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1
|
|
|
|
|
|
|
|
